See also the following Ypatent Pages: Business links and Promoting your invention and helpful licensing links

manufacturing your business  and   financing a biotechnology company  and  YLicense

License Your Own Invention on Ypatent and Companies which Help You License Your Invention

Licensing is one of the best ways to commercialize your invention. There are two main types of licenses in the IP world. The first is called a "non-exclusive license" and the second is called an "exclusive license." If you grant a non-exclusive license to someone on your invention, you retain the right to make, use, sell and license your inventions to others. In contrast, you will give up this right if you grant an exclusive license.

Licensing with NIH

Licensing from NIH (see NIH Office of Technology Transfer (OTT)) is an attrative option for startup companies. Unlike many university based license agreements, NIH licenses do not require sponsored research agreements which can add significant costs to R&D programs and expense to an already cash strapped small biotech company. Licensees with NIH also do not give up any co-marketing rights or downstream developmental rights. Research tool licenses carry no grantbacks or reach-through rights. For example, the licensee is not required to grant back any usage rights to the imporvements that it may develop subsequent to the license agreement. The lecensee is also not required to share with NIH any future profits that may be made as a result of improvements to the original discovery. In sum, IP derived form new discoveries made with NIH licensed tolls remains unencumbered.

See also educational resources at NIH

See NIH annual Research Festival

Model Licensing Forms

Licensing and related forms from NIH

In addition to model licensing forms, the links above contain Cooperative Research and Development agreements (CRADAs), Clinical Trail Agreements (CTAs) and Material Transfer Agreements (MTAs).

CRADS involve mutually beneficial joint research where each party provides unique resources, skills and fudning. In this arrangement, the scope of research work to be carried out and the license options granted to discvoeries emanating form the joint research are stated. For example, a CTA often involves a compound or therapeutic modality which is proprietary to a company that desires the clincial trail infrastructure that NIH possesses. NIH generally enters into these agreements in cases where such trails would be difficult or impossible to run in other places. CRADA can facilitate financial support for an NIH lab, while providing the collaborating company with preferential access to the NIH scientifist's future work and expertsie during the research or clinical collaborat easiest for a bioentrepreneur to access this expertise is to simply approach the agency officialy through the various technology development coordinator offices located in the individual instiutes of the NIH. See technology coordinators at NIH

The material transfer agreement (MTA) is used for exchaing propritary research reagents, which is used by sceintifists worldwide.

Companies Engaged in the Assitance of other Companies in Licensing Technology

UTEK

Books